This study analyzed adverse drug event (ADE) signals associated with metreleptin using the FDA Adverse Event Reporting System (FAERS) to provide insights for safe clinical use. Data from 1 January 201
Data from Adverse Event Evaluation Form [CRF 95] Study Description A two-phase study that tested a behavioral intervention to treat depression in HIV-positive adolescents and young adults. Sites were
Datová sada obsahuje přehled nežádoucích událostí (NU), jejich rozdělení podle zdravotnického zařízení nebo typu poskytovatele zdravotních služeb (ZZ/PZS) a roku, ve kterém k nežádoucí události došlo
A phase 2, double-blind, placebo-controlled trial evaluated apremilast efficacy, safety, and pharmacodynamics in adults with moderate to severe atopic dermatitis (AD). Overall design: Patients were ra